Compare CLMT & BST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | CLMT | BST |
|---|---|---|
| Founded | 1916 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Finance Companies |
| Sector | Energy | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.5B |
| IPO Year | 2006 | N/A |
| Metric | CLMT | BST |
|---|---|---|
| Price | $19.57 | $40.86 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $20.45 | N/A |
| AVG Volume (30 Days) | ★ 740.4K | 140.2K |
| Earning Date | 11-07-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 7.33% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $4,048,000,000.00 | N/A |
| Revenue This Year | $0.16 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $7.68 | $27.87 |
| 52 Week High | $23.75 | $44.50 |
| Indicator | CLMT | BST |
|---|---|---|
| Relative Strength Index (RSI) | 58.81 | 52.13 |
| Support Level | $18.99 | $40.74 |
| Resistance Level | $19.80 | $41.55 |
| Average True Range (ATR) | 0.69 | 0.77 |
| MACD | 0.08 | 0.22 |
| Stochastic Oscillator | 92.25 | 83.66 |
Calumet Inc is a producer of specialty products, including base oils, specialty oils, solvents, esters, and waxes, as well as a variety of fuel and fuel-related products, including asphalt and heavy fuel oils. The company manufactures, formulates, and markets a variety of specialty branded products to customers in various consumer-facing and industrial markets. Its segments include: Specialty Products and Solutions; Montana/Renewables; Performance Brands; and Corporate. The company generates maximum revenue from Fuels, asphalt and other by-products.
BlackRock Science and Technology Trust is a closed-end management investment company. Its investment objective is to provide income and total return through a combination of current income, current gains, and long-term capital appreciation. It focuses on investing, under a normal market condition in equity securities of science and technology companies.